haemophilia Archives – Cambridge Enterprise

Cambridge spin-out ApcinteX shares clinical trial results from its study of SerpinPC

05 February 2021

Cambridge spin-out ApcinteX begins dosing haemophilia patients in second part of clinical trial

Cambridge spin-out ApcinteX starts clinical trials of novel haemophilia drug

22 October 2019

Cambridge Enterprise joins in £14m funding round for spin-out ApcinteX Limited

02 February 2017

XO1

Potential new treatment for haemophilia developed by Cambridge researchers

27 October 2016